Brief: ANI Pharmaceuticals Announces FDA Approval And Launch Of Indomethacin Oral Suspension, USP
16/01/2024 11:51
Jan 16 (Reuters) - ANI Pharmaceuticals Inc ANIP.O :
* ANI PHARMACEUTICALS ANNOUNCES THE FDA APPROVAL AND LAUNCH
OF
INDOMETHACIN ORAL SUSPENSION, USP
Source text for Eikon: ID:nGNX9sPRmV
Further company coverage: ANIP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ANI Pharmaceuticals
See all newsU.S. RESEARCH ROUNDUP-Airbnb, HII, Tesla
ANI Pharmaceuticals Q1 revenue rises 21%, adjusted EPS beats estimates
Brief: ANI Pharmaceuticals Q1 Adjusted EPS USD 2.05 Vs. IBES Estimate USD 1.3
U.S. STOCKS ON THE MOVE-Conagra, Oracle, Replimune
U.S. STOCKS ON THE MOVE-Allogene Therapeutics, Adobe, Williams-Sonoma